U.S. stocks slid on renewed worries the Federal Reserve could raise rates sooner than Wall Street anticipates. Boston Fed President Eric Rosengren said the market odds for rate hikes are too low and too slow. Fed funds futures currently only place a September hike with chances greater than 50 percent. Factory orders in February slumped, marking their third decline in four months. Orders for equipment in the energy sector were sharply lower, tumbling just over 20 percent, as weaker oil prices continue to beat up the industry. Medical device maker Edwards Lifesciences (EW) hit an all-time high after a number of Wall Street firms including JPMorgan and BTIG raised their ratings. Gap (GPS) was higher after Keybanc upgraded to OVERWEIGHT with a $36 price target. TheStreet's Keris Lahiff has details from Wall Street.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.